Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study.
Saved in:
| Title: | Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study. |
|---|---|
| Authors: | Sarkozy C; Hematology Departement, Institut Curie, Saint Cloud, Université de Versailles Saint-Quentin (UVSQ), Versailles, France., Chartier L; Statistiques, Lymphoma Academic Research Organisation (LYSA), Piérre-Benite, France., Ribrag V; Haematology Department, Institut Gustave Roussy, Villejuif, France., Gressin R; Haematology Department, Univ. Grenoble Alpes. University Hospital, Grenoble France & Institute For Advanced Biosciences (INSERM U1209), Grenoble, France., Geisler CH; Haematology Department, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Kluin-Nelemans HC; Haematology Department, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Thieblemont C; Université Paris Cité, Inserm U1153, Paris, France.; Hemato-oncology Department, Hôpital Saint Louis, Assistance Publique - Hôpitaux de Paris, Paris, France., Morschhauser F; Univ. Lille, CHU Lille, ULR 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France., Lemonnier F; Haematology Department, Groupe Hospitalier Mondor, Assistance Publique Hôpitaux de Paris, Paris, France., Safar V; Haematology Department, Centre hospitalier Lyon Sud - 145 Chemin du Grand Revoyet, Pierre Bénite, France., Tessoulin B; Haematology Department, Nantes University Hospital, Nantes, France., Oberic L; Haematology Department, Institut universitaire du cancer Toulouse- Oncopole, Toulouse, France., Damaj G; Haematology Department, Normandie University, Hematology Institute, Caen, France., Ghesquières H; Haematology Department, Centre hospitalier Lyon Sud - 145 Chemin du Grand Revoyet, Pierre Bénite, France., Bouabdallah K; Haematology Department, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France., Casasnovas RO; Haematology Department, Centre Hospitalier Universitaire Dijon, INSERM UMR1231, Dijon, France., Houot R; Department of Hematology, University Hospital of Rennes, UMR U1236, INSERM, University of Rennes, French Blood Establishment, Rennes, France., Klapper W; Institut für Pathologie, Sektion Hämatopathologie und Lymphknotenregister, University Hospital Schleswig-Holstein Campus Kiel/Christian-Albrechts University Kiel, Kiel, Germany., Burroni B; Department of Pathology, Cochin University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France., Pott C; University Hospital Schleswig-Holstein Campus Kiel/Christian-Albrechts University Kiel, Kiel, Germany., Delfau-Larue MH; Biological Haematology and Immunology Department, Groupe Hospitalier Mondor, Assistance Publique Hôpitaux de Paris, INSERM U955, Paris, France., Macintyre E; Biological Haematology Department, Necker-Enfants malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France., Callanan M; University of Burgundy-INSERM 1231-CHU Dijon, DIJON, France., Jerkeman M; Department of Oncology, Institute of Clinical Sciences, Lund University and Skane University Hospital SE22185, Lund, Sweden., Unterhalt M; Department of Medicine III, LMU University Hospital, Munich, Germany., Hoster E; Institute for Medical Information Processing, Biometry, and Epidemiology, LMU Munich, Munich, Germany., Dreyling M; Department of Medicine III, LMU University Hospital, Munich, Germany., Le Gouill S; Hematology Departement, Institut Curie, Saint Cloud, Université de Versailles Saint-Quentin (UVSQ), Versailles, France., Hermine O; Haematology Department, Necker-Enfants malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.; Université Paris Cité, Institut Imagine, Laboratory of Hematological Disorders, INSERM UMR1163, Paris, France., Cheminant M; Haematology Department, Necker-Enfants malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. morgane.cheminant@aphp.fr.; Université Paris Cité, Institut Imagine, Laboratory of Hematological Disorders, INSERM UMR1163, Paris, France. morgane.cheminant@aphp.fr. |
| Source: | Blood cancer journal [Blood Cancer J] 2025 Apr 24; Vol. 15 (1), pp. 78. Date of Electronic Publication: 2025 Apr 24. |
| Publication Type: | Journal Article; Validation Study |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
